… In this narrative review, we will focus on the scientific evidence supporting treatment with
inhaled corticosteroids (ICS) in COPD, including treatment with combinations of long acting β-…

… clinical practice guidelines for chronic obstructive pulmonary disease (COPD), the addition
of inhaled corticosteroids (… However, ICS are largely overprescribed in clinical practice, and …

Current guidelines for the management of chronic obstructive pulmonary disease (COPD)
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …

… in the treatment of patients with asthma, because they demonstrate that in actual clinical
practice, inhaled corticosteroids reasonably control asthma symptoms while remaining relatively …

… corticosteroids but is not yet practical in clinical practice [57]. … an inhaled β 2 -agonist) the
dose of inhaled corticosteroid … dose inhaler (MDI) and mouth washing with a dry powder inhaler …

… , and theory has been borne out in clinical practice. The pharmacological properties of the
different inhaled corticosteroids can be compared and advantages tentatively deduced. Any …

… who, in clinical practice, would not require treatment with inhaled steroids should be interpreted
with caution. The overwhelming evidence is that clinically important systemic effects are …

… We discuss the evidence for systemic absorption from ICSs, for biological effects following
absorption, and for systemic adverse effects in clinical practice. The latter section focuses on …

… In Dutch analyses of actual drug use in clinical practice, the majority of patients with COPD
used ICSs, irrespective of the degree of airflow limitation and occurrence of exacerbations …

… In clinical practice, inhaled corticosteroids effectively reduce airway inflammation in asthma
patients. Improvements in lung function and reduction of asthma symptoms with the use …